A ROC analysis indicated that EPHX4 possesses considerable discriminative capability in the clinical identification of both LUAD (Figure 3A) and lung squamous cell carcinoma (LUSC) (Figure 3B), with expression levels proficiently differentiating tumor tissues from their normal counterparts. This evidence concerns the gene EPHX4 and neoplasm.